Table 2.
Factors associated with adjuvant hormonal therapy use in multivariate logistic regression analysis (n = 2,033)a
| OR | 95% CI | P value | |
|---|---|---|---|
| Age (years) | < 0.01 | ||
| 65 – 69 | 1.00 | ||
| 70 – 74 | 0.87 | 0.68 – 1.10 | 0.26 |
| 75 – 79 | 0.92 | 0.70 – 1.20 | 0.55 |
| 80 – 89 | 0.56 | 0.41 – 0.77 | < 0.01 |
| Race/Ethnicity | 0.91 | ||
| Non-Hispanic white | 1.00 | ||
| Other | 1.02 | 0.73 – 1.43 | |
| Marital Status | 0.36 | ||
| Married | 1.00 | ||
| Widowed | 0.86 | 0.68 – 1.08 | 0.20 |
| Divorced | 0.85 | 0.59 – 1.21 | 0.37 |
| Never Married | 1.25 | 0.73 – 2.14 | 0.41 |
| Geographic Location | 0.16 | ||
| California | 1.00 | ||
| Illinois | 1.35 | 1.01 – 1.81 | 0.04 |
| New York | 1.23 | 0.94 – 1.62 | 0.14 |
| Florida | 1.06 | 0.83 – 1.36 | 0.62 |
| Educational Level | < 0.01 | ||
| < High school | 1.00 | ||
| High school graduate | 1.55 | 1.07 – 2.24 | 0.02 |
| > High school | 1.81 | 1.26 – 2.61 | < 0.01 |
| Annual Income ($) | 0.87 | ||
| 15,000 or less | 1.00 | ||
| 15,001 – 25,000 | 1.05 | 0.74 – 1.49 | 0.78 |
| 25,001 – 50,000 | 0.98 | 0.69 – 1.40 | 0.93 |
| More than 50,000 | 0.91 | 0.62 – 1.34 | 0.64 |
| Missing | 0.75 | 0.52 – 1.08 | 0.12 |
| Medication Coverage | 0.87 | ||
| None of the cost | 1.00 | ||
| Some of the cost | 0.93 | 0.71 – 1.23 | 0.61 |
| Almost all to all of the cost | 0.94 | 0.72 – 1.23 | 0.65 |
| Tangible Social Support | 0.22 | ||
| < 4.0 (least) | 1.00 | ||
| 4.0 – 5.0 (most) | 0.87 | 0.69 – 1.09 | |
| Emotional/Informational Support | 0.02 | ||
| < 3.5 (least) | 1.00 | ||
| 3.5 – 5.0 (most) | 1.30 | 1.03 – 1.63 | |
Abbreviations: CI, confidence interval; OR, odds ratio
a
Excludes 158 patients with missing information in any variable except income.
b
Comorbidity and tumor stage were not significant factors and were therefore not included in the model.